Significance of the PAP Complex in Thermal Injury
- 1 June 1995
- journal article
- research article
- Published by SAGE Publications in Clinical and Applied Thrombosis/hemostasis
- Vol. 1 (3) , 210-214
- https://doi.org/10.1177/107602969500100306
Abstract
Plasmin-antiplasmin complex (PAP) has been reported previously as elevated in sepsis syndrome and infection. To assess the value of PAP complex and the thrombin-antithrombin (TAT)/PAP ratio in thermal injury, sixty patients were studied within the first 36 h, at 5-7 days following injury, and at time of infection. The patient population was categorized by percent burn (2° + 3°): 40%, n = 20. PAP increased significantly between days 1 and 5 in the p < 0.01) and in the >40% group (p < 0.002). The TAT/PAP ratio was elevated on day 1 in the 20-40% group ( p < 0.04) and the >40% group (p < 0.001), and decreased to near normal limits on day 5 in both groups. These data revealed a proportionately greater incidence of coagulation activation than fibrinolysis on day 1. Of 16 episodes of sepsis syndrome or severe infection, PAP was elevated, average 14.6 nM (normal < 8 nM), in 10 (63%) patients. PAP was significantly elevated on day 5 during the clinically stabilized phase regardless of percent burn (p = 0.01). In individuals who had a burn wound surface area of >40%, the PAP values were significantly higher for those who did not survive (p < 0.03). PAP did not appear to correlate with the type of burn or with inhalation. Although PAP complex levels were elevated in thermal injury patients with sepsis syndrome or severe infection, they were not a specific predictor of infection. In conclusion, PAP complex and the TAT/PAP ratio provided useful information as to the fibrinolytic status of thermally injured patients with correlation to survival, but without correlation to sepsis and infection.Keywords
This publication has 10 references indexed in Scilit:
- THE EFFECT OF BURN WOUND SIZE ON HEMOSTASISPublished by Wolters Kluwer Health ,1992
- Plasminogen Activation In Vivo upon Intravenous Infusion of DDAVPThrombosis and Haemostasis, 1992
- Thrombin Vs. Plasmin generation in disseminated lntravascular coagulation associated with various underlying disordersAmerican Journal of Hematology, 1990
- An Enzyme-Linked Immunosorbent Assay (ELISA) for the Measurement of Plasmin-α2-Antiplasmin Complex in Human Plasma - Application to the Detection of In Vivo Activation of the Fibrinolytic SystemThrombosis and Haemostasis, 1986
- Elevated plasmin-α2-antiplasmin complex levels in hereditary angioedema: Evidence for the efficiency of the intrinsic fibrinolytic systemThrombosis Research, 1985
- Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.BMJ, 1985
- Functional Activities and Concentrations of Plasmin Inhibitors in Normal Subjects and D. I. C. PatientsThrombosis and Haemostasis, 1982
- Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasmaBlood, 1979
- Neoantigenic expression in enzyme·inhibitor complexes a means to demonstrate activation of enzyme systemsBiochimica et Biophysica Acta (BBA) - Enzymology, 1978
- Fast-acting plasmin inhibitor in human plasmaBlood, 1978